Skip to main content

Table 3 Albumin quotient (QAlb) distribution in the study population by sex, age and specific disease status

From: Increased age and male sex are independently associated with higher frequency of blood–cerebrospinal fluid barrier dysfunction using the albumin quotient

 FemalesMalesp
ALL, n (%)718 (59.4)491 (40.6) 
QAlb: median (IQR)4.87 (3.69–6.88)7.18 (4.91–11.30)< 0.0001
 Age 16–40 years: median (IQR)4.19 (3.28–5.41)5.74 (4.40–9.20)< 0.0001
 Age 41–60 years: median (IQR)5.03 (3.88–7.83)7.33 (4.87–11.26)< 0.0001
 Age > 60 years: median (IQR)6.52 (4.93–10.96)8.87 (5.82–15.43)0.0008
MS, n (%)204 (68.7)93 (31.3) 
 QAlb: median (IQR)4.10 (3.27–5.36)5.22 (4.15–7.61)< 0.0001
OIND, n (%)132 (47.0)149 (53.0) 
 QAlb: median (IQR)6.68 (4.54–13.1)9.22 (5.65–15.00)0.0172
NIND, n (%)146 (49.2)151 (50.8) 
 QAlb: median (IQR)5.09 (3.87–6.58)6.34 (4.64–9.42)< 0.0001
UNK, n (%)236 (70.7)98 (29.3) 
 QAlb: median (IQR)4.89 (3.70–7.38)8.48 (6.2–12.4)< 0.0001
  1. Mann–Whitney u-test was used for all comparisons
  2. ALL patient groups analysed as a whole, MS multiple sclerosis, NIND non-inflammatory neurological diseases, OIND other inflammatory neurological diseases, UNK unknown-neurological diagnosis